Therefore, the action of CagA presumably results in the accumulation of genetic mutations in BRCA1/2 (i.e., PVs in BRCA1/2), which triggers the development and progression of GC by indirectly inducing the cancerous transformation of gastric mucosal epithelial cells. The gene discussed is S100A8; the disease is gastric cancer.